Indications and uses
Temporarily relieves cold & flu-like symptoms such as: Body aches Headache Fever Chills Fatigue
Anatra
- Manufacturer
- Anatra LLC
- Effective date
- 2025-10-07
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 3
- Source
- full-release
- Hydrated at
- 2026-06-01 01:38:07
Label at a glance#
ProductAnatra
Active ingredientCAIRINA MOSCHATA HEART/LIVER AUTOLYSATE
Label structure9 sections
Dosage and administration
ANATRA may be taken regularly as a preventative. Adults and children 2 years of age and older: Dissolve entire tablet in mouth every 6 hours, up to 3 times a day. Children under two years of age: Ask a Doctor.
Label contents#
Full prescribing information#
Active Ingredient
Anas barbariae. HPUS - 200 CK
Purpose
To reduce the duration and severity of cold & flu-like symptoms. The letters HPUS indicate that this ingredient is officially included in the Homeopathic Pharmacopeia of the United States.
Uses
Temporarily relieves cold & flu-like symptoms such as:
- Body aches
- Headache
- Fever
- Chills
- Fatigue
Warnings
Ask a Doctor before usein children under 2 years of age.
Stop use and ask a Doctor if symptoms persist for more than 3 days or worsen.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children.
Directions
ANATRA may be taken regularly as a preventative.
Adults and children 2 years of age and older: Dissolve entire tablet in mouth every
6 hours, up to 3 times a day. Children under two years of age: Ask a Doctor.
Other Information
Do not use if carton is open and/or bottle is open.Each 0.775g dose contains 0.5g of sugar. Store at 68-77°F (20-25°C).
Inactive ingredients
Beta Carotene, Citric Acid, Crospovidone, Dextrose,Lactose, Magnesium Stearate, Nat. Orange Flavor, Reb. A (Stevia LeafExtract), Silicon Dioxide, Stearic Acid
Questions/Comments?
Distributed by Anatra LLC 3250 NE 1st Ave., Suite 305 Miami, FL 33137 (844) ANATRA-1
Product label
Product Linked Resources#
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| QR code link | QR Code |  qr-codes.io/mVOmE7 | Updated_image60_2_V2.jpg, Updated_image30_2_V2.jpg, Updated_image30_1_V2.jpg, Updated_image60_1_V2.jpg |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83641-001-01 | Anatra | 30 in 1 BOTTLE, PLASTIC | TABLET | 30 | 3 | |
| 83641-001-02 | Anatra | 60 in 1 BOTTLE, PLASTIC | TABLET | 60 | 3 |
Products#
Every source-derived product name is available through these pages.
- Anatra
- Anas Barbariae
- BETA CAROTENE
- CITRIC ACID MONOHYDRATE
- CROSPOVIDONE, UNSPECIFIED
- DEXTROSE, UNSPECIFIED FORM
- LACTOSE, UNSPECIFIED FORM
- MAGNESIUM STEARATE
- REBAUDIOSIDE A
- SILICON DIOXIDE
- STEARIC ACID
- CAIRINA MOSCHATA HEART/LIVER AUTOLYSATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 83641-001 | 83641-001-01, 83641-001-02 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Older Hydrated Versions#
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 2 | 2025-01-13 | full-release | 2026-06-01 00:52:34 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Anatra | ANAS BARBARIAE | Anatra LLC | 4562fa87-ed88-42fb-b530-e600aea351d9 | 2025-10-07 | Warnings | 83641-001-01 83641-001-02 83641-001 83641000102 83641000101 4097d2e5-5d3f-b62a-e063-6294a90a882f 4562fa87-ed88-42fb-b530-e600aea351d9 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.